DADAL VASODILATOR INJECTION FOR HORSES

Ország: Ausztrália

Nyelv: angol

Forrás: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Vedd Meg Most

Betegtájékoztató Betegtájékoztató (PIL)
20-06-2017
Termékjellemzők Termékjellemzők (SPC)
20-06-2017

Aktív összetevők:

DI-ISOPROPYLAMINE DICHLOROACETATE; SODIUM GLUCONATE

Beszerezhető a:

RANVET PTY. LIMITED

INN (nemzetközi neve):

sodium gluconate(19mg/mL)+di-isopropylamine dichloroac(20mg/mL)

Gyógyszerészeti forma:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

Összetétel:

DI-ISOPROPYLAMINE DICHLOROACETATE UNGROUPED Active 20.0 mg/ml; SODIUM GLUCONATE MINERAL-SODIUM-SALT Active 19.0 mg/ml

db csomag:

50mL

Osztály:

VM - Veterinary Medicine

Terápiás csoport:

HORSE | COLT | DONKEY | ENDURANCE HORSE | FILLY | FOAL | GELDING | HIGH PERFORMANCE HORSES | HORSES AT STUD | MARE | PACER | POL

Terápiás terület:

CARDIOVASCULAR SYSTEM

Terápiás javallatok:

VASCULAR SYSTEM REACTANT | CARDIAC STIMULANT | CORONARY VASODILATOR | NAVICULAR DISEASE | REACTANTS ON VASCULAR SYSTEM | RESPIRATORY STIMULANT | TICK PARALYSIS | VASCULAR SYSTEM | VASODILATION

Termék összefoglaló:

Poison schedule: 4; Withholding period: WHP:MEAT: Not to be used in horses that may be slaughtered for human consumpt ion.; Host/pest details: HORSE: [VASCULAR SYSTEM REACTANT]; Vasodilator Injection for horses.

Engedélyezési státusz:

Registered

Engedély dátuma:

2022-07-01

Betegtájékoztató

                                ~mLRIP
r
IDN
ANIMA
L
RFHHDY
HEP
OllT
OF
REACH
OF
CHILDRE
N
FOR
ANIMAL TREATMENT
ONLY
DADAL
VASODILA
TOR
IIIJECTIOIJ
F
OR
HOR,E
S
Actl\'e
C:)rrsl~uen
lS
.
SODLL)M
GI
I)(,ONATE
'
S
m
~
.!
m
L
DI
-
ISCP
ROPY
JAMIN8
DLCHL)LOF003CEM
TE
.20MG/ML
BACTERLOSTAT
N"LPA STAI O.15 %
vas
cdu
a rcr ir
uec
tc n
FOL
Horses
50
ML
                                
                                Olvassa el a teljes dokumentumot
                                
                            

Termékjellemzők

                                RANVET DADAL
ChemWatch Material Safety Data Sheet
CHEMWATCH 4966-81
For Workplace - Small Volume Use Only.
Issue Date: THU 6-MAR-2008
CD 2004/3 Page 1 of 8
Section 1 - CHEMICAL PRODUCT AND COMPANY IDENTIFICATION
PRODUCT NAME
RANVET DADAL
SYNONYMS
PRODUCT USE
Vasodilator injectable for horses.
SUPPLIER
Company: Ranvet Pty Ltd (ACN: 001 606 033)
Address:
10-12 Green Street
East Botany
NSW, 2019
Telephone: +61 2 9666 1744
Emergency Tel: +61 44 18 493 533 A/H
Fax: 02 9666 1755
Section 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
NON-HAZARDOUS SUBSTANCE. NON-DANGEROUS GOODS.
According to the Criteria of NOHSC, and the ADG Code.
POISONS SCHEDULE
S4
RISK
SAFETY
Section 3 - COMPOSITION / INFORMATION ON INGREDIENTS
NAME
CAS RN
%
diisopropylamine dichloroacetate
660-27-5
2
performance additives nonhazardous
<1
water
7732-18-5
>60
continued...
RANVET DADAL
ChemWatch Material Safety Data Sheet
CHEMWATCH 4966-81
For Workplace - Small Volume Use Only.
Issue Date: THU 6-MAR-2008
CD 2004/3 Page 2 of 8
Section 4 - FIRST AID MEASURES
SWALLOWED
If poisoning occurs, contact a doctor or Poisons Information Centre.
EYE
If this product comes in contact with eyes:
- Wash out immediately with water.
- If irritation continues, seek medical attention.
- Removal of contact lenses after an eye injury should only be
undertaken by
skilled personnel.
SKIN
If skin or hair contact occurs:
- Flush skin and hair with running water (and soap if available).
- Seek medical attention in event of irritation.
INHALED
- If fumes or combustion products are inhaled remove from contaminated
area.
- Other measures are usually unnecessary.
NOTES TO PHYSICIAN
Treat symptomatically.
Section 5 - FIRE FIGHTING MEASURES
EXTINGUISHING MEDIA
The product contains a substantial proportion of water, therefore
there are no
restrictions on the type of extinguishing media which may be used.
Choice of
extinguishing media should take into account surrounding areas.
Though the material is non-combustible, evaporation of water from the
mixture,
caused by the heat o
                                
                                Olvassa el a teljes dokumentumot